Home > Insider Trading > Filing (0001104659-14-061090)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492674	T2 Biosystems Inc.	TTOO	Surgical & Medical Instruments & Apparatus (3841)	204827488

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	Planet Zanett Inc 135 E 57Th St New York NY 10022	No	No	Yes	No
1250195	Steve Elms	888 Seventh Ave 29Th Fl New York NY 10106	No	No	Yes	No
1297291	J Dennis Purcell	Auxilium Pharmaceuticals, Inc. 160 West Germantown Pike Norristown PA 19401	No	No	Yes	No
1444717	Aisling Capital Iii Lp	888 Seventh Avenue, 30Th Fl New York NY 10106	No	No	Yes	No
1532634	Aisling Capital Partners Iii Lp	Aisling Capital Llc 888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No
1532635	Aisling Capital Partners Iii Llc	Aisling Capital Llc 888 Seventh Avenue 30Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-12	2,068,755	$0.00	2,068,755	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-08-12	454,545	$11.00	2,523,300	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Convertible Preferred Stock	Disposition	2014-08-12	2,967,033	$0.00	1,745,313	$0.00
Common Stock	Series E Convertible Preferred Stock	Disposition	2014-08-12	549,851	$0.00	323,441	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.